Circulating Tumor DNA Based Adjuvant Chemotherapy in Stage II Colon Cancer Patients: the MEDOCC-CrEATE Trial

Clinical trial NCT06434896 · RECRUITING

Trial details

NCT number: NCT06434896
Sponsor: UMC Utrecht
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Circulating Tumor DNA Recurrence Colon Cancer Stage II

Start date: 2020-03-05
Primary completion: 2026-12-01
Enrollment: 1320

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.